SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Report
of Foreign Private Issuer
Pursuant
to Rule 13a - 16 under
the
Securities Exchange Act of 1934
For the
month of May 2008
ICON
plc
(Registrant’s
name)
0-29714
(Commission
file number)
South
County Business Park, Leopardstown, Dublin 18, Ireland.
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under
cover Form 20-F or Form 40-F.
|
Yes X
|
No
|
Indicate
by check mark whether the registrant is submitting the Form 6-K in paper as
permitted by Regulation S-T Rule 101(b)(1):
|
Yes
|
No X
|
Indicate
by check mark whether the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule
101(b)(7):
|
Yes
|
No X
|
Indicate
by check mark whether the registrant by furnishing the information contained in
this Form is also thereby furnishing the information to the Commission pursuant
to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
|
Yes
|
No X
|
If “Yes”
is marked, indicate below the file number assigned to the registrant in
connection with Rule 12g3-2(b):82 N/A
Other
Events.
The
registrant hereby incorporates by reference the press release attached hereto as
Exhibit 99.1 into this report.
EXHIBIT
INDEX
|
Exhibit
Number |
Description
of Exhibit
|
|
99.1
|
Press
Release - ICON plc announces appointment of Professor Dermot Kelleher to
the Board of Directors.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
ICON
plc
|
||
|
May 29, 2008
|
/s/ Peter Gray | |
|
Date
|
Peter
Gray
|
|
|
Chief
Executive Officer
|
Exhibit 99.1
ICON
plc announces appointment of Professor Dermot Kelleher to the Board of
Directors.
(NASDAQ:ICLR)
(ISIN: IE0001827041)
Dublin, Ireland, May 28 2008 – ICON
plc, a global provider of outsourced development services to the
pharmaceutical, biotechnology and medical device industries, today announced the
appointment of Professor Dermot Kelleher as a non-executive
Director.
Professor
Kelleher was appointed unanimously by ICON’s board of directors and in
accordance with the company’s Articles of Association will stand for re-election
by ICON’s shareholders at the Company’s next annual general
meeting.
Professor
Kelleher is currently Head of the School of Medicine at Trinity College, Dublin,
Ireland and Director of the Institute of Molecular Medicine in
Dublin. His research interests are broad ranging in the fields of
Gastroenterology, Immunology and Molecular Biology and over a distinguished
thirty year career he has led significant research projects in this
field. Alongside his notable academic appointments he has served as a
visiting research scientist with Lilly Research laboratories and has been a
founder of a number of biotechnology companies.
“We are
delighted to welcome Professor Dermot Kelleher to the Board of ICON”, commented
Chairman Dr John Climax. “With his extensive experience in clinical
research and in particular his academic insight into novel medicines, he will
prove an invaluable addition to the Board.”
ICON
plc is a global provider of outsourced development services to the
pharmaceutical, biotechnology and medical device industries. The Company
specializes in the strategic development, management and analysis of programs
that support clinical development - from compound selection to Phase I-IV
clinical studies. ICON teams have successfully conducted over 1,900 development
projects and over 2,300 consultancy engagements across all major therapeutic
areas. ICON currently has approximately 6,150 employees, operating from 69
locations in 36 countries. Further information is available at
www.iconplc.com.
Source:
ICON plc
Contact:
Investor Relations 1-888-381-7923 or
Ciaran
Murray CFO + 353 –1-291-2000
Both at
ICON.